Search

Displaying results 8731 - 8740 of 10000 in total
  1. Drug

    Tipelukast

    go.drugbank.com/drugs/DB12435
    Investigational

    Tipelukast is under investigation for the treatment of IPF and Idiopathic pulmonary fibrosis.

  2. Drug

    Pf-04531083

    go.drugbank.com/drugs/DB12468
    Investigational

    Pf-04531083 has been investigated for the treatment of Pain and Chronic Pain.

  3. Drug

    JQ1

    go.drugbank.com/drugs/DB17021
    Experimental

    First-in-class potent and selective inhibitor of the BRD4 signaling pathway.[A252967]

  4. Drug

    XL-888

    go.drugbank.com/drugs/DB12981
    Investigational

    XL888 has been used in trials studying the treatment of Cancer and Melanoma.

  5. Drug

    ABG-023

    go.drugbank.com/drugs/DB18829
    Experimental

    ABG-023 is a glucagon analog which is soluble and solution-stable.[L50778]

  6. Drug

    Daidzein

    go.drugbank.com/drugs/DB13182
    Investigational

    Categories: Hormones, Hormone Substitutes, and Hormone Antagonists, Estrogens, Non-Steroidal
  7. Drug

    Ketodarolutamide

    go.drugbank.com/drugs/DB15647
    Experimental

    Ketodarolutamide, a nonsteroidal antiandrogen (NSAA), is the major active metabolite of darolutamide.

    Categories: Antiandrogens, non-steroidal
  8. Drug

    Navamepent

    go.drugbank.com/drugs/DB21096
    Investigational

    Navamepent is under investigation in clinical trial NCT02329743 (Efficacy and Safety of RX-10045 Ophthalmic Solution for Ocular Inflammation and Pain in Cataract Surgery).

  9. Drug

    Aderbasib

    go.drugbank.com/drugs/DB21288
    Investigational

    Aderbasib is under investigation in clinical trial NCT01254136 (Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer).

  10. Drug

    ISB 1442

    go.drugbank.com/drugs/DB18475
    Investigational

    ISB 1442 is a bispecific, biparatopic antibody targeting CD38 and CD47